Viewing Study NCT02413008


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-03 @ 3:15 PM
Study NCT ID: NCT02413008
Status: COMPLETED
Last Update Posted: 2019-08-05
First Post: 2015-04-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Sponsor: ITF Research Pharma, S.L.U.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Vaginal Atrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None vaginal atrophy View
None breast cancer View
None vaginal dryness View
None aromatase inhibitor View